No Data
Sipai Health Technology Boosts Share Award Scheme
Sipai Health (00314.HK): The trustee purchased a total of 29.28 million shares under the 2023 stock incentive plan.
Gelonghui October 21st. Sipai Health (00314.HK) announced that the company has been informed by the trustee that as of the date of this announcement, the trustee has purchased a total of 29.28 million shares in the market, with a total price of approximately 0.195 billion Hong Kong dollars, accounting for approximately 3.84% of the total number of shares issued by the company as of the date of this announcement. The shares purchased will be used as rewards for eligible participants under the plan to encourage them to contribute to the group. As of the date of this announcement, the company has not yet granted any shares under the plan.
Sipai Health Tech Announces New Share Registrar
SIPAI HEALTH: 2024 Interim Report
Performance: At the mid-year mark, SinoMab BioScience Limited (00314.HK) reduced its losses to RMB 78.2 million.
SP Healthcare (00314.HK) announced its interim results for the six months ended in June, with revenue recording RMB 2.364 billion, a year-on-year decrease of 3%. Losses narrowed from RMB 92.32 million in the same period last year to RMB 78.2 million, with a loss per share of 12 cents. No interim dividend will be paid.
Sipai Health Reports Growth and Shrinking Losses in 2024 H1
No Data
No Data